Executive Summary
The COVID-19 pandemic has had a devastating impact on global tuberculosis control efforts, reversing years of progress towards WHO End TB Strategy targets. Wide-ranging efforts are needed to tackle these intersecting pandemics, the leading infectious causes of death worldwide.
In the first of a Series of three papers, Keertan Dheda and colleagues review the effects of COVID-19 on global efforts to reduce the burden of tuberculosis, identifying points of intersection between the two pandemics and highlighting new strategies for tuberculosis control. Hanif Esmail and colleagues focus on opportunities to optimise the management of tuberculosis across the disease spectrum. Finally, Grant Theron and colleagues address challenges in tuberculosis diagnostics, considering the promise of rapid, sputum-free diagnostic technologies and tests with potential for decentralised deployment.
The Series can be accessed here.
SEE ALSO:
- The Lancet Infectious Diseases: World TB Day 2022: aligning COVID-19 and TB innovations to save lives and to end TB
For more TB news, check out the latest edition of the TB Online Weekly Newsletter (#10, 30 March 2022).
Related HIV and Co-Infections News
-
The Lancet Global Health: Untangling the complex relationship between HIV-exposure and TB in children: A narrative review
-
Research Centre Borstel: Long-term cure rates for multidrug-resistant TB much better than expected
-
Liverpool School of Tropical Medicine: New pooled testing toolkit to help expand TB diagnosis to ‘missed millions’
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.